Directs, develops, organizes, and implements the ovarian cancer (OCa)HEOR strategy with concurrence of functional management to allow the development of each asset to proceed expeditiously and smoothly toward registration, PR&A and market launch in compliance with national and international governmental regulations for various asset programs. HSOL reports to Senior Director, Solid Tumor Oncology HEOR Strategy Team Lead and may have 1-4 direct reports.